Aquestive Therapeutics Inc

NASDAQ:AQST   4:00:00 PM EDT
4.26
+0.16 (+3.90%)
7:59:49 PM EDT: $4.35 +0.09 (+2.11%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)383.25M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$12.46 Million
Adjusted EPS-$0.08
See more estimates
10-Day MA$4.46
50-Day MA$3.52
200-Day MA$2.24
See more pivots

Aquestive Therapeutics Inc Stock, NASDAQ:AQST

30 Technology Drive, Warren, New Jersey 07059
United States of America
Phone: +1.908.941.1900
Number of Employees: 135

Description

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients� therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.